ANVS stock closed up more than 75% today after Annovis announced encouraging clinical trial results for its Parkinson's drug, buntanetap. More
Articles
3 Cybersecurity Stocks to Sell in July Before They Crash & Burn
The industry has become a saturated market, and with generative AI boom cooling down, here are three cybersecurity stocks to sell in July. More
7 Dividend Aristocrats That Will Have Investors in High-Yield Heaven
These Dividend Aristocrats all have payouts yielding three times or more the average yield of the S&P 500. More
3 Oil Stock Steals That Wall Street Is Overlooking
Explore overlooked oil stocks with potential for growth, benefiting from stable oil prices and balanced global supply and demand dynamics. More
Why July Should Be a Strong Month for the Stock Market
I expect July to be a strong month for Wall Street, so I’ll use today’s Market 360 to explain why. Then I’ll share an event that could also impact the market this month… and how you can profit from it. More
7 Little-Known Penny Stocks That Can Turn $10K Into $1 Million
Check out these explosive penny stocks with massive growth potential that could turn a modest $10,000 investment into a life-changing $1 million. More
3 Dividend Stocks to Sell in July Before They Crash & Burn
These are some of the dividend stocks to sell before they get worse. Each of these stocks has underperformed the market. More
